Soleus Capital Management, L.P. - ESSA PHARMA INC ownership

ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 55 filers reported holding ESSA PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of ESSA PHARMA INC
ValueSharesWeighting
Q3 2023$13,247,120
+16.8%
4,287,094
+2.0%
1.22%
-3.1%
Q2 2023$11,345,654
-7.8%
4,202,094
+1.4%
1.26%
-1.1%
Q1 2023$12,310,997
+26.3%
4,145,117
+7.1%
1.28%
-8.9%
Q4 2022$9,750,868
+102.9%
3,869,392
+46.5%
1.40%
+114.2%
Q3 2022$4,806,000
-63.4%
2,640,539
-36.7%
0.65%
-68.1%
Q2 2022$13,132,000
-49.7%
4,168,799
-1.3%
2.05%
-39.2%
Q1 2022$26,103,000
-47.9%
4,223,799
+19.8%
3.37%
-32.8%
Q4 2021$50,061,000
+118.2%
3,525,457
+22.9%
5.01%
+40.2%
Q3 2021$22,944,000
-64.1%
2,868,023
+28.1%
3.58%
-63.6%
Q2 2021$63,943,000
+6.3%
2,238,104
+8.1%
9.83%
-9.2%
Q1 2021$60,135,000
+112.2%
2,070,052
-12.9%
10.84%
+189.7%
Q4 2020$28,342,000
+124.8%
2,375,681
+30.0%
3.74%
-44.0%
Q3 2020$12,606,000
-2.3%
1,826,980
-12.3%
6.68%
-9.2%
Q2 2020$12,909,000
+55.1%
2,082,185
+0.1%
7.36%
-24.0%
Q1 2020$8,322,000
-7.4%
2,080,421
+27.3%
9.68%
+11.7%
Q4 2019$8,989,0001,634,3698.67%
Other shareholders
ESSA PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 4,145,117$12,310,9971.28%
BVF INC/IL 8,748,629$25,983,4280.95%
Ally Bridge Group (NY) LLC 236,583$702,6520.92%
PFM Health Sciences, LP 4,161,461$12,359,5390.55%
Bellevue Group AG 7,898,583$23,458,7920.34%
Rhenman & Partners Asset Management AB 356,500$1,051,6750.12%
Orbimed Advisors 1,198,337$3,559,0610.07%
Privium Fund Management (UK) Ltd 20,032$61,4980.05%
Rock Springs Capital Management LP 524,944$1,559,0840.04%
Hunting Hill Global Capital, LLC 10,000$29,7000.02%
View complete list of ESSA PHARMA INC shareholders